University Hospital Ghent
Ghent, 9000, Belgium
NCT Number: NCT05128370
For several years now, it has been demonstrated that the upper limb plays an important role in the function of an efficient and balanced gait pattern in healthy adults. After a stroke, the reduced muscle strength has a clear influence on the gait pattern, but also on the active movement possibilities of the upper limb. However, the role of the upper limb during gait is not sufficiently explored in the literature. The gold standard for motion analysis is a 3D analysis performed with infrared cameras capturing reflective markers during gait. Unfortunately, it is not possible for all people after a stroke to undergo this examination. On the one hand, patients must already have a certain degree of independence with regard to gait. On the other hand, not all centers have access to this expensive accommodation. There are some validated observation scales for people after stroke to describe the gait based on a 2D video image. This method is much more accessible and can be applied by any therapist. However, to date there has been little attention paid to the upper limb in these observation scales. Therefore, analogous to the observation scales for gait, an observation scale for the upper limb during gait was set up. The use of this scale can add value to the rehabilitation of people after a stroke.
* The treatment team will receive information about the patient's complete movement pattern. * The arm will be more prominent when setting rehabilitation goals related to gait. This can lead to a positive effect on the gait pattern itself, but also to more attention being paid to the arm, which has a more difficult recovery than the leg after a stroke.
The aim of the current study will be
* to determine the inter and intra tester reliability of this visual observation scale * to investigate if the results of the visual observation scale correlate to a 3D assessment performed in a subgroup of participants
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
Ghent, 9000, Belgium
Patients will be walking for 4x10 m. During this walking a 2D video recording in the frontal (back and front view) and sagittal plane (left and right sided view) will be performed.
Supervision of therapist during walking is allowed. Therapist cannot help the patient during walking.
This images will be used to score the visual observation scale (G.A.I.T) and the additional observation scale developed for this study.
In a subgroup of participants from the Ghent University Hospital, a 3D assessment will be made on an instrumented treadmill (GRAIL, Motek), which will be used as a golden standard to compare with.
Additional clinical parameters will be investigated to describe the study group.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The gait pattern of the stroke patients will be scored based on a visual observation scale. Additional components concerning the arm swing have been added to an existing scale.
Time frame: Single point of assessment within one week after the 2D video has been made
Intraclass correlation coefficient between the different raters who rate the same observation at the same time.
Time frame: Assessment at 2 points in time with an interval of 2 weeks.
Intraclass correlation coefficient between the same rater rating the videos within a period of 2 weeks from each other.
Time frame: Single point of assessment within one week
Correlation statistics between items of the upper limb observation scale and kinematic graphs of the 3D assessment which will be performed within a week after the 2D assessment.
Time frame: Single point of assessment within one week after the 2D video has been made
Total score on the upper limb visual observation scale (max score 34)
Time frame: Single point of assessment at assessment day 1
Age, gender, date of birth, stroke date, type of stroke, side of paresis, stroke location
Time frame: Single point of assessment at assessment day 1
Active recovery of the upper limb
Time frame: Single point of assessment at assessment day 1
Active recovery of the lower limb
Time frame: Single point of assessment at assessment day 1
Modified Ashworth Scale (minimum 0 - maximum 4, higher score is more spasticity = worse outcome) of shoulder flexors, extensors, internal rotators, external rotators, adductors, abductors, elbow flexors, elbow extensors, wrist flexors, wrist extensors, finger flexors and finger extensors
Time frame: Single point of assessment at assessment day 1
Goniometric measurement of shoulder flexion, abduction, external rotation, internal rotation and elbow flexion/extension (degrees)
Time frame: Single point of assessment at assessment day 1
UL sensory testing using the Erasmus MC Modificatie van de (revised) Nottigham Sensory Assessment
Time frame: Single point of assessment at assessment day 1
Palpating the gap between the acromion and the humeral head
Time frame: Single point of assessment at assessment day 1
Assessing the trunk impairment using the trunk impairment scale
Time frame: Single point of assessment at assessment day 1
Using a numeric rating scale (0-10) to assess pain at the upper limb during walking
Time frame: Single point of assessment at assessment day 1
Calculating gait speed (m/s) based on the time it takes to complete the 10m walking
University Hospital, Ghent
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03728036
Brain Diseases, Cardiovascular Diseases
Antwerp, Belgium
View Trial DetailsNCT03727919
Brain Diseases, Cardiovascular Diseases
Wilrijk, Antwerp, Belgium
View Trial DetailsNCT02410915
Ambulation Difficulty, Brain Diseases
Danderyd, Stockholm County, Sweden
View Trial DetailsNCT04013971
Brain Diseases, Cardiovascular Diseases
Atlanta, Georgia, United States
View Trial Details